Trial intelligence / Profile preview

Hydrochlorothiazide exposure and skin cancer risk in patients with type 2 diabetes

NL-OMON28736Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Jan 1998
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by University Medical Center Groningen. Started Jan 1998; status: active, not recruiting.

02

Drugs

hydrochlorothiazide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NL-OMON28736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call